New tool aims to slash months-long thyroid dose adjustment to weeks

NCT ID NCT06455371

Recruiting now Symptom relief Sponsor: University Hospital of North Norway Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a decision support tool that uses blood samples from the first two weeks after thyroid surgery to predict the best levothyroxine dose. Normally, dose adjustments take months of trial and error. The trial will enroll 240 patients and compare the tool's guidance to standard care, measuring how quickly patients reach their target thyroid hormone levels and how they feel.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: decision support tool
What this could lead to: If it works, this tool could help patients reach the right thyroid hormone dose faster, reducing months of symptoms like fatigue and brain fog.
What could go wrong: This is a small, early-stage study. The tool may not speed up dose adjustment or improve patient outcomes compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN THYROID NODULES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

differentiated thyroid carcinoma hypothyroidism nodular goiter thyroid cancer thyroid gland disorder Thyroid Neoplasms thyroid tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOTHYROIDISM THYROID THYROID CANCER

Contacts and locations

Locations

Haukeland University Hospital
RECRUITING

Bergen, Norway
Oslo University Hospital
RECRUITING

Oslo, Norway
University Hospital of North Norway
RECRUITING

Tromsø, 9010, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.